Healthcare Intelligence
Genomics & Precision Medicine
Real-time intelligence, expert analysis, and verified research for the Genomics & Precision Medicine industry. Stay ahead in 3 minutes a day.
Stay ahead of Genomics & Precision Medicine in 3 minutes a day.
Expert-verified intelligence delivered to your inbox every morning.
Free forever. No spam. Unsubscribe anytime.
FDA Approves First CRISPR Gene Therapy for Sickle Cell Disease
Vertex and CRISPR Therapeutics receive landmark FDA approval for Casgevy, the first CRISPR-based treatment for sickle cell disease patients.
Read full articleIllumina Launches New NovaSeq X Plus System for High-Throughput Sequencing
Illumina unveils upgraded sequencing platform offering 2.5x higher throughput and 50% cost reduction per genome compared to previous models.
Read full article23andMe Data Breach Affects 6.9 Million Users' Genetic Information
Personal genetic data of millions exposed in cyberattack, raising concerns about privacy and security of consumer genomics databases.
Read full articleAI Model Predicts Cancer Drug Response with 95% Accuracy
Stanford researchers develop machine learning system that analyzes tumor genomics to predict chemotherapy effectiveness in cancer patients.
Read full articleRoche Acquires Precision Medicine Startup for $2.7 Billion
Pharmaceutical giant Roche purchases GeneDx to expand its genomic diagnostics portfolio and personalized medicine capabilities.
Read full articleUK Launches 100,000 Genomes Project Phase 2 with £300M Funding
NHS England expands genomic medicine program to sequence genomes of cancer and rare disease patients for personalized treatments.
Read full articleBreakthrough in Liquid Biopsy Detects 50 Cancer Types from Blood
GRAIL's new multi-cancer early detection test shows 93% specificity in identifying cancers from circulating tumor DNA in blood samples.
Read full articleChina Approves First Domestic CAR-T Cell Therapy for Lymphoma
JW Therapeutics receives regulatory approval for locally developed CAR-T treatment, marking milestone in China's precision medicine sector.
Read full articleFDA Approves First CRISPR Gene Therapy for Sickle Cell Disease
Vertex and CRISPR Therapeutics receive landmark FDA approval for Casgevy, the first CRISPR-based treatment for sickle cell disease patients.
Read full articleIllumina Launches New NovaSeq X Plus System for High-Throughput Sequencing
Illumina unveils upgraded sequencing platform offering 2.5x higher throughput and 50% cost reduction per genome compared to previous models.
Read full article23andMe Data Breach Affects 6.9 Million Users' Genetic Information
Personal genetic data of millions exposed in cyberattack, raising concerns about privacy and security of consumer genomics databases.
Read full articleAI Model Predicts Cancer Drug Response with 95% Accuracy
Stanford researchers develop machine learning system that analyzes tumor genomics to predict chemotherapy effectiveness in cancer patients.
Read full articleRoche Acquires Precision Medicine Startup for $2.7 Billion
Pharmaceutical giant Roche purchases GeneDx to expand its genomic diagnostics portfolio and personalized medicine capabilities.
Read full articleUK Launches 100,000 Genomes Project Phase 2 with £300M Funding
NHS England expands genomic medicine program to sequence genomes of cancer and rare disease patients for personalized treatments.
Read full articleBreakthrough in Liquid Biopsy Detects 50 Cancer Types from Blood
GRAIL's new multi-cancer early detection test shows 93% specificity in identifying cancers from circulating tumor DNA in blood samples.
Read full articleChina Approves First Domestic CAR-T Cell Therapy for Lymphoma
JW Therapeutics receives regulatory approval for locally developed CAR-T treatment, marking milestone in China's precision medicine sector.
Read full articleStay ahead of Genomics & Precision Medicine in 3 minutes a day.
Live opportunity intelligence for your market, delivered to your inbox every morning. Read it over coffee.
Free forever. No spam. Unsubscribe anytime.